In summary, this meta-analysis suggests that no significantly increased cancer risk associated with p21 3′ UTR rs1059234 polymorphism, however, marginally increased risks were observed for rs1059234 in SCCHN. The gene discussed is CDKN1A; the disease is head and neck squamous cell carcinoma.